Stage 4 Lung Cancer and Brain Metastases: A Complete Guide

Brain metastases are serious, but their presence does not mean there are no treatment options. Modern lung cancer care often involves a combination of systemic treatments, advanced radiotherapy, targeted therapies, immunotherapy, and supportive care. The most appropriate approach depends on the type of lung cancer, the number and size of brain metastases, symptoms, molecular test results, and the patient’s overall health.

What brain metastases mean in lung cancer

Brain metastases are cancer deposits that have spread to the brain from another part of the body. In this case, the cancer cells started in the lung and later travelled to the brain.

This is not the same as primary brain cancer. Even when cancer is found in the brain, it is still treated as lung cancer if the cells originated in the lung. This distinction matters because treatment decisions are guided by the behaviour and biology of the lung cancer, not only by the location of the metastases.

When lung cancer has spread to the brain, it is part of metastatic disease. Understanding the wider picture of metastatic cancer treatment can help patients make sense of why treatment may involve both brain-directed therapy and whole-body treatment.

Why lung cancer can spread to the brain

Lung cancer can spread through the bloodstream or lymphatic system. The brain is one of the recognised sites where advanced lung cancer may spread, particularly in some forms of non-small cell lung cancer and small cell lung cancer.

The likelihood of brain metastases can depend on several factors, including the lung cancer subtype, molecular features, stage of disease, and how the cancer has behaved over time.

This is one reason why modern lung cancer treatment increasingly relies on detailed testing.

Molecular testing can identify genetic changes, such as EGFR, ALK, ROS1, or other alterations, that may influence treatment choices. In some patients, targeted therapies can reach the brain and help control disease there as well as elsewhere in the body.

Symptoms brain metastases may cause

Symptoms vary depending on where the metastases are located, their size, and whether they are causing swelling or pressure within the brain.

Possible symptoms can include

1. Headaches
2. Nausea
3. Seizures
4. Weakness
5. Changes in balance
6. Speech difficulties
7. Vision changes
8. Confusion
9. Memory changes
10. Personality changes

Some brain metastases are found before they cause symptoms, particularly when brain imaging is performed as part of staging or monitoring. Others are discovered after new neurological symptoms develop.

These symptoms should always be assessed promptly. They do not always mean that cancer has spread to the brain, but they may require urgent investigation.

How brain metastases are diagnosed

Brain metastases are usually diagnosed using imaging. MRI is often the preferred scan because it provides detailed images of the brain and can detect small areas of disease. CT scans may also be used, particularly in urgent situations or when an MRI is not suitable.

Doctors may also review previous scans, biopsy results, molecular testing, and the overall pattern of disease elsewhere in the body. This helps determine whether the brain lesions are consistent with metastatic lung cancer and whether other areas of the body also require treatment.

Accurate diagnosis is important because the number, size, and location of brain metastases can strongly influence treatment recommendations.

Treatment options for brain metastases from lung cancer

Treatment is individualised. There is no single standard approach that applies to every patient with lung cancer and brain metastases.

Options may include stereotactic radiosurgery (SRS), which delivers highly focused radiation to one or more brain metastases. Despite the name, it is not surgery but a precise form of radiotherapy designed to treat specific tumour sites while minimising exposure to surrounding brain tissue.

In some cases, stereotactic radiotherapy (SRT) may be used instead, delivering similarly targeted radiation over a small number of treatment sessions rather than a single treatment.

Whole brain radiotherapy may be considered in selected situations, particularly when there are multiple brain metastases or more widespread involvement within the brain. Surgery may also be an option if a metastasis is large, causing pressure, or if tissue confirmation is required.

Systemic treatments can also play an important role. These may include immunotherapy, targeted therapies, chemotherapy, or combinations of treatments depending on the tumour biology and previous treatment history.

These factors all help shape a personalised lung cancer treatment plan that considers both the brain metastases and the cancer throughout the rest of the body.

The role of targeted therapy and immunotherapy

For some patients, treatment has changed significantly because of targeted therapies and immunotherapy, including recent breakthrough treatments that have improved outcomes.

Certain targeted therapies are designed for cancers with specific mutations and may have activity in the brain. This can be particularly important for patients with EGFR or ALK alterations, where drug treatment may help control disease inside and outside the brain.

Immunotherapy may also be used in selected patients, depending on factors such as PD-L1 expression, cancer subtype, previous treatment, and overall health.

These treatments are not suitable for everyone, and they are not interchangeable. The most appropriate option depends on the details of the diagnosis and the goals of treatment.

Living with stage 4 lung cancer and brain metastases

A diagnosis of brain metastases can feel overwhelming, but many patients continue to receive active treatment. The aim may be to control cancer, reduce symptoms, preserve neurological function, and maintain quality of life.

Supportive care is also important. This may include medicines to reduce swelling, seizure management where needed, rehabilitation support, symptom control, and psychological support.

Palliative care may also be introduced alongside active treatment. This does not mean that treatment has stopped. It means that additional support is being provided to help manage symptoms and improve quality of life.

Questions patients may want to ask

After a diagnosis of brain metastases, it can help to ask clear questions during oncology appointments.

Useful questions may include:

• How many brain metastases are present?
• Are they causing symptoms or swelling?
• Is stereotactic radiosurgery appropriate?
• Would whole brain radiotherapy be considered?
• Do my molecular test results affect treatment?
• Are targeted therapy or immunotherapy options available?
• What is the aim of treatment?
• Would a second opinion be helpful?

These questions can help patients understand how treatment decisions are being made and what options may be available.

About Dr James Wilson

Stage 4 lung cancer with brain metastases often requires careful treatment planning, particularly when decisions involve advanced radiotherapy, targeted therapies, immunotherapy, and systemic cancer treatment.

Dr James Wilson is a consultant clinical oncologist in private practice in London with expertise in lung cancer, metastatic disease, advanced radiotherapy, immunotherapy, targeted therapies, and systemic cancer care. He helps patients understand complex diagnoses and provides clear, personalised guidance around treatment options and second opinions.